Pharmacokinetics of glucosteroids in severe head injury. Experimental studies in rat brain after cold lesion. 1990

H Kostron, and L Russegger
Clinic for Neurosurgery, University of Innsbruck, Austria.

The treatment of brain edema after severe head injury remains controversial. We investigated the uptake kinetics and pharmacokinetics of glucocorticoids in rat brain after cold lesion, employing tritium-labeled dexamethasone or tritium-labeled triamcinolone acetonide (TA). The normal brain, as demonstrated on isolated cells, revealed a saturable, time-dependent uptake of dexamethasone (rate of uptake, 5 nm/mg protein/min at 37 degrees C). This clearly defined uptake is replaced by a simple diffusion like uptake after the trauma. The pharmacokinetical studies demonstrated a rapid decline of the TA concentration after a bolus injection in the brain tissue after the trauma. Within 30 min only 11% of the initial concentration could be discovered in the traumatized brain tissue. However, after a discontinuous administration of TA, a steady state was reached in the normal brain after 24 hr (0.26 micrograms TA/g). In the traumatized brain the concentration increased steadily amounting to 0.34 micrograms TA after 24 hr. The continuous infusion of TA resulted in an equal high concentration in normal brain than after the discontinuous administration. The continuous infusion of TA, however, produced the highest concentration of TA in the traumatized brain after 24 hr (0.79 micrograms TA/g) (p less than 0.05 as compared with the discontinuous injection). Our results demonstrate that the widely used discontinuous administration of steroids result in low tissue concentration, which might account partly for the low efficiency of steroids in traumatic brain edema. The continuous administration of the steroid TA increases the concentration in the traumatized tissue and might therefore be beneficial in the treatment of brain edema after severe head injury.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001929 Brain Edema Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6) Brain Swelling,Cerebral Edema,Cytotoxic Brain Edema,Intracranial Edema,Vasogenic Cerebral Edema,Cerebral Edema, Cytotoxic,Cerebral Edema, Vasogenic,Cytotoxic Cerebral Edema,Vasogenic Brain Edema,Brain Edema, Cytotoxic,Brain Edema, Vasogenic,Brain Swellings,Cerebral Edemas, Vasogenic,Edema, Brain,Edema, Cerebral,Edema, Cytotoxic Brain,Edema, Cytotoxic Cerebral,Edema, Intracranial,Edema, Vasogenic Brain,Edema, Vasogenic Cerebral,Swelling, Brain
D001930 Brain Injuries Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. Brain Lacerations,Acute Brain Injuries,Brain Injuries, Acute,Brain Injuries, Focal,Focal Brain Injuries,Injuries, Acute Brain,Injuries, Brain,Acute Brain Injury,Brain Injury,Brain Injury, Acute,Brain Injury, Focal,Brain Laceration,Focal Brain Injury,Injuries, Focal Brain,Injury, Acute Brain,Injury, Brain,Injury, Focal Brain,Laceration, Brain,Lacerations, Brain
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H Kostron, and L Russegger
June 2000, Pflugers Archiv : European journal of physiology,
H Kostron, and L Russegger
January 1979, Journal of neurosurgical sciences,
H Kostron, and L Russegger
November 1989, Journal of neurochemistry,
H Kostron, and L Russegger
January 1990, Acta neurochirurgica. Supplementum,
H Kostron, and L Russegger
January 1974, Neuroradiology,
H Kostron, and L Russegger
May 1987, Drug intelligence & clinical pharmacy,
Copied contents to your clipboard!